dc.contributor.author
Peh, Elisa
dc.contributor.author
Szott, Vanessa
dc.contributor.author
Reichelt, Benjamin
dc.contributor.author
Friese, Anika
dc.contributor.author
Rösler, Uwe
dc.contributor.author
Plötz, Madeleine
dc.contributor.author
Kittler, Sophie
dc.date.accessioned
2023-09-05T08:26:29Z
dc.date.available
2023-09-05T08:26:29Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/40701
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-40422
dc.description.abstract
Background
Effective strategies are urgently needed to control Campylobacteriosis, one of the most important foodborne gastrointestinal diseases worldwide. Administering bacteriophages (phages) is under evaluation as a possible intervention strategy in primary poultry production to reduce the public health risk of human infection. A major challenge is the translation of results from small-scale animal studies to large broiler flocks. In this study, the in vitro lytic activity of 18 Campylobacter-specific group II phages and 19 group III phages were examined singly, and in different combinations from the same group and from both groups using a planktonic killing assay. Based on these results, a combination of phage NCTC 12,673 (group III) and vB_CcM-LmqsCPL1/1 (group II) was selected for in vivo application in a seeder bird model to study its effectiveness under conditions as close as possible to field conditions. One hundred eighty Ross 308 broiler chickens were divided into a control and a treatment group. Ten days post hatch, seeder birds were orally inoculated with the C. jejuni target strain. Phages were administered via drinking water at a total concentration of 107 PFU/mL four, three, and two days before necropsy.
Results
Combining group II and group III phages resulted in significantly higher in vitro growth inhibition against the C. jejuni target strain BfR-CA-14,430 than single application or combinations of phages from the same group. The results of the animal trial showed that the application of the two phages significantly reduced Campylobacter counts in cloacal swabs. At necropsy, Campylobacter counts in colonic content of the treatment group were significantly reduced by 2 log10 units compared to the control group.
Conclusions
We demonstrated that combining phages of groups II and III results in significantly increased lytic activities. The in vitro results were successfully translated into practical application in a study design close to field conditions, providing new data to apply phages in conventional broiler flocks in the future. Phage application reduced the fecal Campylobacter excretion and Campylobacter concentrations in the colon of broilers.
en
dc.format.extent
12 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Phage therapy
en
dc.subject
Campylobacter
en
dc.subject
Susceptibility
en
dc.subject
Antibacterial
en
dc.subject
Drinking water
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::630 Landwirtschaft::630 Landwirtschaft und verwandte Bereiche
dc.title
Bacteriophage cocktail application for Campylobacter mitigation - from in vitro to in vivo
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
209
dcterms.bibliographicCitation.doi
10.1186/s12866-023-02963-1
dcterms.bibliographicCitation.journaltitle
BMC Microbiology
dcterms.bibliographicCitation.volume
23
dcterms.bibliographicCitation.url
https://doi.org/10.1186/s12866-023-02963-1
refubium.affiliation
Veterinärmedizin
refubium.affiliation.other
Institut für Lebensmittelsicherheit und -hygiene
refubium.affiliation.other
Institut für Tier- und Umwelthygiene
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1471-2180
refubium.resourceType.provider
WoS-Alert